Xiaomei Gao

Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study

Yongxiang Tang, Jian Li, S-L Hu, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer

Zhi Liu, Cong Luo, X. Zu, 2022, Journal of translational medicine.

Optimization of prostate cancer patient lymph node staging via the integration of neutrophil–lymphocyte ratios, platelet–lymphocyte ratios, and 68Ga‐PSMA‐PET‐derived SUVmax values

Y. Gan, Yinzhao Wang, Shuo Hu, 2022, The Prostate.

Nanotechnology in cancer diagnosis: progress, challenges and opportunities

Yongheng Chen, Maoyu Li, Ting Liu, 2019, Journal of Hematology & Oncology.

A prospective comparative study of [^68Ga]Ga-RM26 and [^68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer

Y. Gan, Shuo Hu, Yongxiang Tang, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

[18F]FDG PET metabolic patterns in mesial temporal lobe epilepsy with different pathological types.

Haoyue Zhu, Shuo Hu, Yongxiang Tang, 2023, European radiology.

Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma

Ye Zhang, Yunfan Zhang, Yongheng Chen, 2023, Pharmaceuticals.